Representative Transactions
For our Representative Transactions, click here.
Palomino Laboratories Inc. Announced Closing of $15 Million Private Placement (OTCQB: PALX)
Crone advised Palomino Laboratories Inc. (OTCQB: PALX), an optical data communications technology company, in connection with its $17 million private placement of common stock.
PALO ALTO, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- Palomino Laboratories Inc. (OTCQB: PALX) (the “Company”), an optical data communications technology company developing a way to move data faster and more efficiently using light from GaN-based MicroLEDs instead of traditional copper wires, is pleased to announce that it has raised $15,095,412 in a private placement offering. In the offering, the Company sold 3,773,853 shares of its common stock at a purchase price of $4.00 per share.
This milestone represents a critical step in the Company’s mission to revolutionize AI data center interconnectivity through cutting-edge optical solutions that drastically reduce energy consumption and enhance data transmission density.
“We are pleased to announce the successful closing of our $15 million equity financing, which reflects strong investor confidence in Palomino’s technology and long-term vision,” said Jeffrey B. Shealy, Co-founder & CEO of the Company. “This capital positions Palomino Laboratories Inc. to accelerate commercialization and scale its MicroLED-based optical interconnect solutions for next-generation AI and data infrastructure.”
The Company is committed to advancing its differentiated GaN MicroLED photonic platform that will offer superior speed, energy efficiency, and packaging innovations ideal for AI data centers and other mission-critical applications. The Company’s technology roadmap aligns closely with national semiconductor priorities such as the CHIPS/NIST initiatives, aiming to secure onshore manufacturing and strengthen ties with federal programs.
About Palomino Laboratories Inc.
Palomino is an optical data communications company pioneering high-speed, energy-efficient data transfer using tiny light beams, including Gallium Nitride (GaN) MicroLED devices. Our innovation targets power-hungry systems such as AI servers, cloud computing, and supercomputers, offering a transformative alternative to traditional copper wiring.
About The Crone Law Group, P.C.
The Crone Law Group, P.C. is an international law firm headquartered in New York. We represent domestic and international clients in complex corporate and securities transactions. We are renowned for our expertise in the most complex securities, corporate finance matters, capital markets, initial public offerings (IPOs), uplistings, mergers and acquisitions (M&A), litigation, intellectual property and patent law, tax law, and immigration law, while providing our clients with close, personal service not available at larger, less relationship-focused firms.
Meet our team members click here
To contact The Crone Law Group info@cronelawgroup.com
Our Bond, Inc. Announced its Direct Listing on the Nasdaq Global Market (Nasdaq: OBAI)
New York, NY, Feb. 5, 2026— Our Bond, Inc., the creator of the world’s first AI-powered Preventative Personal Security platform, announced that it became a publicly listed company by way of a direct listing. Trading on the Nasdaq commenced on February 4, 2026 under symbol OBAI. In connection with the listing, the company was valued at $428,450,000.
New York, NY, Feb. 5, 2026— Our Bond, Inc., the creator of the world’s first AI-powered Preventative Personal Security platform, announced that it became a publicly listed company by way of a direct listing. Trading on the Nasdaq commenced on February 4, 2026 under symbol OBAI. In connection with the listing, the company was valued at $428,450,000.
World’s First AI-powered Preventative Personal Security
Our Bond is a global leader in AI-powered Preventative Personal Security, a new category that helps corporations, cities, universities, and families proactively enhance the personal security and peace of mind of their people across demographics, geographies, and roles. Our Bond’s platform uniquely offers a 24/7 Personal Security Companion that combines artificial intelligence with live personal security agents around the world to detect risk, provide guidance, deter perpetrators, coordinate response, and deliver reassurance at scale.
With over 1.4 million security service requests, including over 10,000 emergencies and life-saving situations, and customers including some of the world’s largest companies, Our Bond is proven operationally, technologically, and commercially. The private security market is projected to reach $438B, and Our Bond’s unique AI-powered platform positions it to be a potential winner in this category moving forward.
“We see this as a key opportunity for us to accelerate our growth and scale our infrastructure to meet the growing demand for our service,” said Our Bond’s CEO and Founder Doron Kempel, a serial technology entrepreneur who sold his prior companies to IBM and HPE for almost a billion dollars.
About Our Bond
Our Bond is an international company headquartered in New York City – with command centers around the world – that is redefining personal security through its AI-powered Preventative Personal Security platform. The company has invested more than $100 million to date in its technology, operations, and global expansion.
Our Bond is trusted by leading corporations, cities, and universities, and has already supported more than 1.4 million security service requests, including over 10,000 emergencies and life-saving interventions. Our Bond operates in 28 countries and growing, positioning itself as a new global standard for personal security and peace of mind.
About The Crone Law Group, P.C.
The Crone Law Group, P.C. represented Our Bond in connection with its initial registration statement with the U.S. Securities and Exchange Commission and its application for listing on the Nasdaq Global Market. The Crone Law Group, P.C. is an international law firm headquartered in New York. We represent domestic and international clients in complex corporate and securities transactions. We are renowned for our expertise in the most complex securities, corporate finance matters, capital markets, initial public offerings (IPOs), uplistings, mergers and acquisitions (M&A), litigation, intellectual property and patent law, tax law, and immigration law, while providing our clients with close, personal service not available at larger, less relationship-focused firms.
Meet our team members click here
To contact The Crone Law Group info@cronelawgroup.com
SMJ International Holdings Inc. Announced Closing of $10 Million Initial Public Offering (NYSE: SMJF)
SINGAPORE – (BUSINESSWIRE) – SMJ International Holdings Inc. (“SMJ” or the “Company”), a Singapore-based premium flooring specialist that distributes a wide range of premier flooring products under its proprietary “SMJ” brand across Asia markets, announced the closing its initial public offering (the “Offering”) of an aggregate 2,500,000 Class A ordinary shares par value US$0.0002 per share at a price of US$4.00 per share to the public (the “Offering Price”), for a total of US$10,000,000 of gross proceeds to the Company, before deducting underwriting discounts and other offering expenses.
SINGAPORE-(BUSINESS WIRE)-SMJ International Holdings Inc. (“SMJ” or the “Company”), a Singapore-based premium flooring specialist that distributes a wide range of premier flooring products under its proprietary “SMJ” brand across Asia markets, announced the closing of its initial public offering (the “Offering”) of an aggregate 2,500,000 Class A ordinary shares par value US$0.0002 per share at a price of US$4.00 per share to the public (the “Offering Price”), for a total of US$10,000,000 of gross proceeds to the Company, before deducting underwriting discounts and other offering expenses.
The Crone Law Group, led by Cassi Olson, acted as legal counsel for the company.
The Company has granted the underwriter a 45-day option to purchase an additional 375,000 Class A ordinary shares at the Offering Price less the underwriting discounts to cover over-allotments, if any. The Class A ordinary shares are expected to begin trading on the NYSE American under the ticker symbol “SMJF” on December 4, 2025. The Offering is expected to close on or about December 5, 2025, subject to the satisfaction of customary closing conditions.
About SMJ International Holdings Inc.
SMJ International Holdings Inc. and its subsidiaries (“SMJ Group”) are Singapore-based premier flooring specialists that have a well-established reputation and track records with the commercial and institutional sectors in Asia. It specializes in the sale and distribution of a wide range of premier flooring products such as carpet tiles, broadloom carpets and vinyl tiles under its proprietary brand known as “SMJ” in Singapore and over 20 countries mainly in Asia. To meet the increasing demand for green and eco-friendly materials in Asia, SMJ Group also supplies flooring products that have been certified as environmentally friendly to support government initiatives in promoting sustainable building practices in Asia.
About The Crone Law Group, P.C.
The Crone Law Group, P.C. is an international law firm headquartered in New York. We represent domestic and international clients in complex corporate and securities transactions. We are renowned for our expertise in the most complex securities, corporate finance matters, capital markets, initial public offerings (IPOs), uplistings, mergers and acquisitions (M&A), litigation, intellectual property and patent law, tax law, and immigration law, while providing our clients with close, personal service not available at larger, less relationship-focused firms.
Meet our team members click here
To contact The Crone Law Group info@cronelawgroup.com
Citius Oncology, Inc. Announces Closing of $9 Million Registered Direct Offering and Concurrent Private Placement (Nasdaq: CTOR)
CRANFORD, N.J., Sept. 10, 2025 /PRNewswire/ – Citius Oncology, Inc. (“Citius Oncology”) (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. (“Citius Pharma”) (Nasdaq: CTXR), a late-stage biopharmaceutical company developing and commercializing first-in-class critical care products, announced the closing of its previously announced registered direct offering and concurrent private placement of an aggregate of 5,142,858 shares of common stock and unregistered warrants to purchase up to an aggregate of 5,142,858 shares of common stock. The combined effective offering price for each share of common stock and accompanying warrant was $1.75. The warrants have an exercise price of $1.84 per share, will be exercisable six months from the date of issuance, and will expire on the five and one-half year anniversary from the date of issuance.
CRANFORD, N.J., Sept. 10, 2025 /PRNewswire/ – Citius Oncology, Inc. (“Citius Oncology”) (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. (“Citius Pharma”) (Nasdaq: CTXR), a late-stage biopharmaceutical company developing and commercializing first-in-class critical care products, announced the closing of its previously announced registered direct offering and concurrent private placement of an aggregate of 5,142,858 shares of common stock and unregistered warrants to purchase up to an aggregate of 5,142,858 shares of common stock. The combined effective offering price for each share of common stock and accompanying warrant was $1.75. The warrants have an exercise price of $1.84 per share, will be exercisable six months from the date of issuance, and will expire on the five and one-half year anniversary from the date of issuance.
The Crone Law Group, led by Casi Olson, represented the sole Placement Agent, Maxim Group LLC.
The gross proceeds to the Company from the registered direct offering and concurrent private placement were approximately $9.0 million before deducting placement agent fees and other offering expenses payable by the Company.
The shares of common stock described above were offered pursuant to a registration statement on Form S-3 (File No. 333-289979), which was filed with the U.S. Securities and Exchange Commission (“SEC”) on September 2, 2025, and was declared effective by the SEC on September 4, 2025. The offering of shares of common stock was made only by means of a prospectus supplement, forming a part of the effective registration statement. A prospectus supplement relating to the shares of common stock has been filed with the SEC. Electronic copies of the prospectus relating to this offering, may also be obtained from Maxim Group LLC, 300 Park Avenue, 16th Floor, New York, New York 10022, Attention: Syndicate Department, by telephone at (212) 895-3745 or by email at syndicate@maximgrp.com. The warrants issued in the concurrent private placement and the shares issuable upon exercise of such warrants were offered in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the “Act”), and Regulation D promulgated thereunder and have not been registered under the Act or applicable state securities laws.
About Citius Oncology, Inc.
Citius Oncology, Inc. (Nasdaq: CTOR) is a platform to develop and commercialize novel targeted oncology therapies. In August 2024, its primary asset, LYMPHIR, was approved by the FDA for the treatment of adults with relapsed or refractory CTCL who had had at least one prior systemic therapy. Management estimates the initial market for LYMPHIR currently exceeds $400 million, is growing, and is underserved by existing therapies. Robust intellectual property protections that span orphan drug designation, complex technology, trade secrets and pending patents for immuno-oncology use as a combination therapy with checkpoint inhibitors would further support Citius Oncology’s competitive positioning.
About The Crone Law Group, P.C.
The Crone Law Group, P.C. is an international law firm headquartered in New York. We represent domestic and international clients in complex corporate and securities transactions. We are renowned for our expertise in the most complex securities, corporate finance matters, capital markets, initial public offerings (IPOs), uplistings, mergers and acquisitions (M&A), litigation, intellectual property and patent law, tax law, and immigration law, while providing our clients with close, personal service not available at larger, less relationship-focused firms.
Meet our team members click here
To contact The Crone Law Group info@cronelawgroup.com
Curanex Pharmaceuticals Inc. Announces Closing of $15 Million Initial Public Offering (Nasdaq: CURX)
Curanex Pharmaceuticals Inc. (Nasdaq: CURX) (“Curanex” or the “Company”), a developmental stage pharmaceutical company focused on discovering and developing botanical drugs for inflammatory diseases, today announced the closing of its initial public offering (the “Offering”) of 3,750,000 shares of common stock at a public offering price of $4.00 per share, for gross proceeds of $15 million, before deducting underwriting discounts and offering expenses. The Offering was conducted on a firm commitment basis. The Company’s shares of common stock began trading on the Nasdaq Capital Market on August 26, 2025 under the ticker symbol “CURX.”
Jericho, New York, Aug. 27, 2025 (GLOBE NEWSWIRE) – Curanex Pharmaceuticals Inc. (Nasdaq: CURX) (“Curanex” or the “Company”), a developmental stage pharmaceutical company focused on discovering and developing botanical drugs for inflammatory diseases, today announced the closing of its initial public offering (the “Offering”) of 3,750,000 shares of common stock at a public offering price of $4.00 per share, for gross proceeds of $15 million, before deducting underwriting discounts and offering expenses. The Offering was conducted on a firm commitment basis. The Company’s shares of common stock began trading on the Nasdaq Capital Market on August 26, 2025 under the ticker symbol “CURX.”
The Crone Law Group, P.C., led by partners Eleanor Osmanoff and Joe Laxague, acted as the U.S. counsel to the Company.
The Company has granted the underwriters an option, exercisable within 45 days from the close of the Offering, to purchase up to 562,500 additional shares of common stock at the public offering price, less underwriting discounts and expenses.
About Curanex Pharmaceuticals Inc
Curanex Pharmaceuticals Inc is a developmental stage pharmaceutical company headquartered in Jericho, New York, dedicated to discovering and developing botanical drugs for inflammatory diseases. Its lead candidate, Phyto-N, is a botanical extract from a single plant with proven anti-inflammatory properties that acts via multiple targets and mechanisms. Phyto-N has a long history of human use, having treated thousands of patients with inflammatory diseases over 30 years in China, demonstrating favorable tolerability.
The Company has validated Phyto-N’s effects in animal models of six inflammatory diseases: ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The primary indication is moderate to severe ulcerative colitis. The Company will advance its lead botanical drug candidate, Phyto-N, through FDA-required studies, IND submission, and into Phase I clinical trials.
About The Crone Law Group, P.C.
The Crone Law Group, P.C. is an international law firm headquartered in New York. We represent domestic and international clients in complex corporate and securities transactions. We are renowned for our expertise in the most complex securities, corporate finance matters, capital markets, initial public offerings (IPOs), uplistings, mergers and acquisitions (M&A), litigation, intellectual property and patent law, tax law, and immigration law, while providing our clients with close, personal service not available at larger, less relationship-focused firms.
Meet our team members click here
To contact The Crone Law Group info@cronelawgroup.com
Kandal M Venture Limited Announces Closing of $8.0 Million Initial Public Offering (Nasdaq: FMFC)
Kandal M Venture Limited (Nasdaq: FMFC) (the “Company”), a contract manufacturer of affordable luxury leather goods with manufacturing operations in Cambodia, today announced the closing of its initial public offering (the “Offering”) of 2,000,000 Class A ordinary shares (the “Class A Ordinary Shares”) at a public offering price of $4.00 per share (the “Offering Price”). The Class A Ordinary Shares began trading on the Nasdaq Capital Market on June 25, 2025, under the symbol “FMFC.”
New York, June 26, 2025 (GLOBE NEWSWIRE) – Kandal M Venture Limited (Nasdaq: FMFC) (the “Company”), a contract manufacturer of affordable luxury leather goods with manufacturing operations in Cambodia, today announced the closing of its initial public offering (the “Offering”) of 2,000,000 Class A ordinary shares (the “Class A Ordinary Shares”) at a public offering price of $4.00 per share (the “Offering Price”). The Class A Ordinary Shares began trading on the Nasdaq Capital Market on June 25, 2025, under the symbol “FMFC.”
The Crone Law Group, P.C., led by Partner Liang Shih, acted as the U.S. Counsel to the underwriters for the offering.
In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 300,000 Class A Ordinary Shares at the Offering Price, less underwriting discounts.
The Offering was conducted on a firm commitment basis. Dominari Securities LLC acted as the representative of the underwriters, and Revere Securities LLC acted as the co-underwriter (collectively, the “Underwriters”) for the Offering.
About The Crone Law Group, P.C.
The Crone Law Group, P.C. is focused on corporate securities, securities compliance, and international business and trade, with significant experience working with domestic and foreign corporate issuers. The firm is unique in its ability to handle the most complex securities, M&A, corporate finance matters, intellectual property, and immigration law issues while providing clients with close, personal, service—not often available at larger, less intimate firms. We represent a select clientele that includes domestic and foreign publicly traded corporations, emerging companies, and entrepreneurs in various industries.
Meet our team members click here.
To contact The Crone Law Group info@cronelawgroup.com
The Crone Law Group is a law firm based in New York with proven international practice. Our firm is focused in the areas of securities, corporate finance, securities compliance, business law and immigration.
Mark Crone, Managing Partner, Joined Industry Leaders to Discuss Impact of New NASDAQ Regulations on Company Listings at Planet MicroCap Showcase
Mark Crone, Managing Partner of The Crone Law Group, P.C., participated in a panel discussion with industry leaders on “How New NASDAQ Changes Affect Which Companies Get Listed—and Which Stay Listed.” The panel was part of the Planet MicroCap Showcase, held April 22–24 at the Paris Hotel in Las Vegas, Nevada.
LAS VEGAS, NV, April 23, 2025 – Mark Crone, Managing Partner of The Crone Law Group, P.C., participated in a panel discussion with industry leaders on “How New NASDAQ Changes Affect Which Companies Get Listed—and Which Stay Listed.” The panel was part of the Planet MicroCap Showcase, held April 22–24 at the Paris Hotel in Las Vegas, Nevada.
The Crone Law Group, P.C. is proud to announce it’s attendance as an event sponsor at the Planet MicroCap showcase being held on April 22-24, 2025, at the Paris Hotel in Las Vegas, Nevada.
LAS VEGAS, NV, April 21, 2025 – “The Crone Law Group is extremely pleased to announce our attendance and sponsorship of the upcoming Planet MicroCap Showcase. It is a great opportunity to connect with clients, update them on our activities, and keep abreast of industry happenings.” Commented Mark Crone, Managing Partner of The Crone Law Group. Attending with Mr. Crone this year will be Joe Laxague, Partner.
On Wednesday, April 24th, Mark Crone, Managing Partner, will be speaking on the panel “How will the New Nasdaq Rules & Regulatory Changes Affect Which Companies Get Listed and Listed Companies Stay Listed?”
LAS VEGAS, NV, April 21, 2025 – “The Crone Law Group is extremely pleased to announce our attendance and sponsorship of the upcoming Planet MicroCap Showcase. It is a great opportunity to connect with clients, update them on our activities, and keep abreast of industry happenings.” Commented Mark Crone, Managing Partner of The Crone Law Group. Attending with Mr. Crone this year will be Joe Laxague, Partner.
On Wednesday, April 24th, Mark Crone, Managing Partner, will be speaking on the panel “How will the New Nasdaq Rules & Regulatory Changes Affect Which Companies Get Listed and Listed Companies Stay Listed?”
TOP WIN International Limited Announces Closing of $10.6 Million Initial Public Offering (Nasdaq: TOPW)
TOP WIN INTERNATIONAL LIMITED (Nasdaq: TOPW) (the “Company” or “Top Win”), a Hong Kong-based wholesaler specializing in trading, distribution, and retail of luxury watches of international brands, announced the successful closing of its initial public offering (the “Offering”) of 2,664,000 ordinary shares (the “Ordinary Shares”) at the price of $4.00 per share (the “Offering Price”).
The Crone Law Group, P.C., led by Partner Liang Shih, acted as the U.S. counsel to the Underwriters for the Offering.
Hong Kong, April 08, 2025 (GLOBE NEWSWIRE) – TOP WIN INTERNATIONAL LIMITED (Nasdaq: TOPW) (the “Company” or “Top Win”), a Hong Kong-based wholesaler specializing in trading, distribution, and retail of luxury watches of international brands, announced the successful closing of its initial public offering (the “Offering”) of 2,664,000 ordinary shares (the “Ordinary Shares”) at the price of $4.00 per share (the “Offering Price”).
The Crone Law Group, P.C., led by Partner Liang Shih, acted as the U.S. counsel to the Underwriters for the Offering.
WF Holding Limited Announces Closing of $8.0 Million Initial Public Offering (Nasdaq: WFF)
KUALA LUMPUR, March 28, 2025 (GLOBE NEWSWIRE) – WF Holding Limited (“WF Holding” or “Company”), a Malaysia-based manufacturer of fiberglass reinforced plastic (FRP) products, announced the successful closing of its initial public offering of 2,000,000 ordinary shares, par value $0.00005 per share (the “Ordinary Shares”), at a public offering price of $4.00 per share.
KUALA LUMPUR, March 28, 2025 (GLOBE NEWSWIRE) – WF Holding Limited (“WF Holding” or “Company”), a Malaysia-based manufacturer of fiberglass reinforced plastic (FRP) products, announced the successful closing of its initial public offering of 2,000,000 ordinary shares, par value $0.00005 per share (the “Ordinary Shares”), at a public offering price of $4.00 per share. The offering generated total gross proceeds of $8 million, before deducting underwriting discounts and other offering expenses. The Company’s Ordinary Shares started trading on the Nasdaq Capital Market on March 27, 2025 under the ticker symbol “WFF.”
Inspire Veterinary Partners Announces Closing of up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules (Nasdaq: IVP)
VIRGINIA BEACH, VA, April 1, 2025 (ACCESS Newswire) – Inspire Veterinary Partners, Inc. (NASDAQ:IVP) (“Inspire” or the “Company”), an owner and provider of pet health care services throughout the U.S., today announced it has closed a securities purchase agreement with an investor to purchase 1,092,896 shares of its common stock (or pre-funded warrants in lieu thereof), Series A warrants to purchase 1,092,896 shares of common stock and Series B warrants to purchase 1,092,896 shares of common stock, pursuant to a registered direct offering for aggregate gross proceeds of approximately $2.0 million (the “Offering”).
VIRGINIA BEACH, VA, April 1, 2025 (ACCESS Newswire) – Inspire Veterinary Partners, Inc. (NASDAQ:IVP) (“Inspire” or the “Company”), an owner and provider of pet health care services throughout the U.S., today announced it has closed a securities purchase agreement with an investor to purchase 1,092,896 shares of its common stock (or pre-funded warrants in lieu thereof), Series A warrants to purchase 1,092,896 shares of common stock and Series B warrants to purchase 1,092,896 shares of common stock, pursuant to a registered direct offering for aggregate gross proceeds of approximately $2.0 million (the “Offering”).
The Crone Law Group sponsors the 37th annual ROTH Conference
NEW YORK, NEW YORK, UNITED STATES OF AMERICA, March 11, 2025 — The Crone Law Group, P.C. is proud to announce its attendance as an event sponsor at the 37th annual ROTH Conference being held on March 16-18, 2025, at the Ritz-Carlton Niguel in Dana Point, California.
“For over 15 years we’ve participated in the conference as a sponsor. It’s a great venue to connect with clients, update them on our activities, and keep informed of industry happenings,” commented Mark Crone, Managing Partner of The Crone Law Group.
NEW YORK, NEW YORK, UNITED STATES OF AMERICA, March 11, 2025 — The Crone Law Group, P.C. is proud to announce its attendance as an event sponsor at the 37th annual ROTH Conference being held on March 16-18, 2025, at the Ritz-Carlton Niguel in Dana Point, California.
“For over 15 years we’ve participated in the conference as a sponsor. It’s a great venue to connect with clients, update them on our activities, and keep informed of industry happenings,” commented Mark Crone, Managing Partner of The Crone Law Group.
The Crone Law Group Client CTRL Group Limited Rings NASDAQ Bell
NEW YORK, New Yok, Feb. 26, 2025 -Crone Law Group client CTRL Group Limited (Nasdaq: MCTR), attended the daily NASDAQ bell ceremony. In honor of the occasion, Mr. Chi Fung, Lau, CEO, rings the Opening Bell.
CLG partner, Eric Mendelson, who lead the deal, was in attendance to celebrate the successful NASDAQ listing.
CTRL Group Limited is an integrated marketing and advertising services provider in Hong Kong specializing in mobile games promotion for the local market, Visit the Nasdaq MarketSite in Times Square.
NEW YORK, New Yok, Feb. 26, 2025 -Crone Law Group client CTRL Group Limited (Nasdaq: MCTR), attended the daily NASDAQ bell ceremony. In honor of the occasion, Mr. Chi Fung, Lau, CEO, rings the Opening Bell.
CLG partner, Eric Mendelson, who lead the deal, was in attendance to celebrate the successful NASDAQ listing.
CTRL Group Limited is an integrated marketing and advertising services provider in Hong Kong specializing in mobile games promotion for the local market, Visit the Nasdaq MarketSite in Times Square.
The Crone Law Group, P.C. acted as Issuer’s Counsel to Fitell Corporation in its Closing of a Registered Direct Offering of up to $10.0 Million (Nasdaq: FTEL).
TAREN POINT, Australia, Feb. 10, 2025 (GLOBE NEWSWIRE) – Fitell Corporation (Nasdaq: FTEL) (“Fitell” or the “Company”), an online retailer of gym and fitness equipment in Australia, announced the closing of its previously announced registered direct offering of 796,813 ordinary shares and an additional investment right to purchase up to 1,195,220 ordinary shares in the form of warrants, at a purchase price of $5.02 per ordinary share and associated warrant. The warrants have an exercise price of $5.02 per share, are exercisable immediately upon issuance and expire three years following the issuance date.
The Crone Law Group, P.C. led by Liang Shih, acted as issuer counsel.
TAREN POINT, Australia, Feb. 10, 2025 (GLOBE NEWSWIRE) – Fitell Corporation (Nasdaq: FTEL) (“Fitell” or the “Company”), an online retailer of gym and fitness equipment in Australia, announced the closing of its previously announced registered direct offering of 796,813 ordinary shares and an additional investment right to purchase up to 1,195,220 ordinary shares in the form of warrants, at a purchase price of $5.02 per ordinary share and associated warrant. The warrants have an exercise price of $5.02 per share, are exercisable immediately upon issuance and expire three years following the issuance date.
The Crone Law Group, P.C. led by Liang Shih, acted as issuer counsel.
Plutus Financial Group Limited Announces Closing of $8.4 Million Initial Public Offering (NasdaqCM: PLUT). The Crone Law Group acted as Counsel to the Issuer.
HONG KONG, Feb. 06, 2025 (GLOBE NEWSWIRE) — Plutus Financial Group Limited (“the “Company”) (NasdaqCM: PLUT), a Hong Kong-based financial services company, announced the closing of its initial public offering (the “Offering”) on February 6, 2025 of 2,100,000 ordinary shares at a public offering price of $4 per ordinary share, for total gross proceeds of $8.4 million. The ordinary shares began trading on Nasdaq Capital Market under the ticker symbol “PLUT” on February 5, 2025. The CLG team was led by Partner, Joe Laxague.
Decent Holding Inc. Announces Closing of $5 Million Initial Public Offering (Nasdaq: DXST)
Yantai, China, Jan. 23, 2025 (GLOBE NEWSWIRE) — Decent Holding Inc. (Nasdaq: DXST) (the “Company”), an established wastewater treatment services provider in China, today announced the closing of its initial public offering (the “Offering”) of 1,250,000 ordinary shares (the “Ordinary Shares”) at a public offering price of $4.00 per share. The Ordinary Shares commenced trading on Nasdaq Capital Market on January 22, 2025, under the ticker symbol “DXST”. The Offering closed on January 23, 2025.
Craft Capital Management LLC and D. Boral Capital LLC acted as underwriters for the Offering. The Crone Law Group, P.C. acted as U.S. securities counsel to the underwriters in connection with the Offering.
The Crone Law Group, P.C. acted as U.S. Securities Counsel to CTRL Group Limited on its $8,000,000 Initial Public Offering
New York, New York, January 29, 2025 -The Crone Law Group, P.C. (“CLG”) acted as U.S. securities counsel to CTRL Group Limited (the “Company”) (NasdaqCM: MCTR), an integrated marketing and advertising services provider in Hong Kong specializing in mobile games promotion for the local market, on its initial public offering (the “Offering”) of 2,000,000 ordinary shares at a public offering price of $4.00 per share, which closed on January 23, 2025. The ordinary shares began trading on the Nasdaq Capital Market under the ticker symbol “MCTR” on January 22, 2025. The CLG team was led by Partner, Eric Mendelson.
New York, New York, January 29, 2025 -The Crone Law Group, P.C. (“CLG”) acted as U.S. securities counsel to CTRL Group Limited (the “Company”) (NasdaqCM: MCTR), an integrated marketing and advertising services provider in Hong Kong specializing in mobile games promotion for the local market, on its initial public offering (the “Offering”) of 2,000,000 ordinary shares at a public offering price of $4.00 per share, which closed on January 23, 2025. The ordinary shares began trading on the Nasdaq Capital Market under the ticker symbol “MCTR” on January 22, 2025. The CLG team was led by Partner, Eric Mendelson.
The Crone Law Group, P.C. advised TMT Acquisition Corp on its $450 million business combination with eLong Power Holding Limited
Ganzhou, China, November 21, 2024 (GLOBE NEWSWIRE) – The Crone Law Group, P.C. acted as U.S. legal advisor to TMT Acquisition Corp (“TMT”) (Nasdaq: TMTCU, TMTC, and TMTCR), a publicly traded special purpose acquisition company that was acquired by eLong Power Holding Limited (“eLong”) (Nasdaq: ELPW). eLong Power is a provider of high-power battery technologies for commercial and specialty vehicles and energy storage systems. The de-SPAC transaction was valued at $450,000,000.
The business combination was effected through a share exchange and subsidiary merger. At the closing, all of TMT’s non-redeeming shareholders exchanged their TMT shares and publicly traded TMT Rights for eLong’s Class A ordinary shares and TMT was merged into eLong’s Cayman Islands subsidiary. TMT is now a subsidiary of eLong and will be delisting from Nasdaq. As part of the transaction, $7,000,000 was raised through concurrent PIPE financing to fund the business combination and ongoing working capital needs of the combined company.
Ganzhou, China, November 21, 2024 (GLOBE NEWSWIRE) – The Crone Law Group, P.C. acted as U.S. legal advisor to TMT Acquisition Corp (“TMT”) (Nasdaq: TMTCU, TMTC, and TMTCR), a publicly traded special purpose acquisition company that was acquired by eLong Power Holding Limited (“eLong”) (Nasdaq: ELPW). eLong Power is a provider of high-power battery technologies for commercial and specialty vehicles and energy storage systems. The de-SPAC transaction was valued at $450,000,000.
The business combination was effected through a share exchange and subsidiary merger. At the closing, all of TMT’s non-redeeming shareholders exchanged their TMT shares and publicly traded TMT Rights for eLong’s Class A ordinary shares and TMT was merged into eLong’s Cayman Islands subsidiary. TMT is now a subsidiary of eLong and will be delisting from Nasdaq. As part of the transaction, $7,000,000 was raised through concurrent PIPE financing to fund the business combination and ongoing working capital needs of the combined company.
Oriental Rise Holdings Limited Announces Closing of $7 Million Initial Public Offering (Nasdaq: ORIS). The Crone Law Group P.C. acted as counsel to the Company.
Ningde, China, Oct. 18, 2024 (GLOBE NEWSWIRE) – Oriental Rise Holdings Limited (“Oriental Rise” or the “Company”) (NasdaqCM: ORIS), an integrated supplier of tea products in mainland China, today announced the closing of its initial public offering (the “Offering”) of 1,750,000 ordinary shares at a public offering price of $4 per share. The ordinary shares began trading on Nasdaq Capital Market under the ticker symbol “ORIS” on October 17, 2024.
Ningde, China, Oct. 18, 2024 (GLOBE NEWSWIRE) – Oriental Rise Holdings Limited (“Oriental Rise” or the “Company”) (NasdaqCM: ORIS), an integrated supplier of tea products in mainland China, today announced the closing of its initial public offering (the “Offering”) of 1,750,000 ordinary shares at a public offering price of $4 per share. The ordinary shares began trading on Nasdaq Capital Market under the ticker symbol “ORIS” on October 17, 2024.
The Crone Law Group P.C. Announces the addition of Charlotte Westfall, Partner
New York, NY, Oct. 01, 2024 (EIN PRESSWIRE) – The Crone Law Group P.C. (CLG) is pleased to announce that Charlotte Westfall has joined us as Partner effective today. Charlotte ‘s practice focuses on capital markets, public company advisory services and Mergers & Acquisitions.
New York, NY, Oct. 01, 2024 (EIN PRESSWIRE) – The Crone Law Group P.C. (CLG) is pleased to announce that Charlotte Westfall has joined us as Partner effective today. Charlotte ‘s practice focuses on capital markets, public company advisory services and Mergers & Acquisitions.